Auteur zoekresultaten :: Library Catalog

1

$Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates$

Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates door Evan C. Chen (15054014)

Gepubliceerd in 2025
Andere auteurs:

Toevoegen aan favorieten

Bewaard in:
2

$Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates$

Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates door Evan C. Chen (15054014)

Gepubliceerd in 2025
Andere auteurs:

Toevoegen aan favorieten

Bewaard in:
3

$Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates$

Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates door Evan C. Chen (15054014)

Gepubliceerd in 2025
Andere auteurs:

Toevoegen aan favorieten

Bewaard in:
4

$Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates$

Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates door Evan C. Chen (15054014)

Gepubliceerd in 2025
Andere auteurs:

Toevoegen aan favorieten

Bewaard in:
5

$Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates$

Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates door Evan C. Chen (15054014)

Gepubliceerd in 2025
Andere auteurs:

Toevoegen aan favorieten

Bewaard in:
6

$Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates$

Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates door Evan C. Chen (15054014)

Gepubliceerd in 2025
Andere auteurs:

Toevoegen aan favorieten

Bewaard in:
7

Supplementary Table S3 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States door Laura E. Stevens (14961009)

Gepubliceerd in 2025
Andere auteurs:

Toevoegen aan favorieten

Bewaard in:
8

Supplementary Table S8 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States door Laura E. Stevens (14961009)

Gepubliceerd in 2025
Andere auteurs:

Toevoegen aan favorieten

Bewaard in:
9

Supplementary Table S4 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States door Laura E. Stevens (14961009)

Gepubliceerd in 2025
Andere auteurs:

Toevoegen aan favorieten

Bewaard in:
10

Supplementary Table S5 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States door Laura E. Stevens (14961009)

Gepubliceerd in 2025
Andere auteurs:

Toevoegen aan favorieten

Bewaard in:
11

Supplementary Table S2 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States door Laura E. Stevens (14961009)

Gepubliceerd in 2025
Andere auteurs:

Toevoegen aan favorieten

Bewaard in:
12

Supplementary Table S6 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States door Laura E. Stevens (14961009)

Gepubliceerd in 2025
Andere auteurs:

Toevoegen aan favorieten

Bewaard in:
13

Supplementary Table S7 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States door Laura E. Stevens (14961009)

Gepubliceerd in 2025
Andere auteurs:

Toevoegen aan favorieten

Bewaard in:
14

Supplementary Table S9 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States door Laura E. Stevens (14961009)

Gepubliceerd in 2025
Andere auteurs:

Toevoegen aan favorieten

Bewaard in:
15

Supplementary Table S1 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States door Laura E. Stevens (14961009)

Gepubliceerd in 2025
Andere auteurs:

Toevoegen aan favorieten

Bewaard in:

Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates door Evan C. Chen (15054014)

Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates door Evan C. Chen (15054014)

Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates door Evan C. Chen (15054014)

Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates door Evan C. Chen (15054014)

Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates door Evan C. Chen (15054014)

Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates door Evan C. Chen (15054014)

Supplementary Table S3 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States door Laura E. Stevens (14961009)

Supplementary Table S8 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States door Laura E. Stevens (14961009)

Supplementary Table S4 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States door Laura E. Stevens (14961009)

Supplementary Table S5 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States door Laura E. Stevens (14961009)

Supplementary Table S2 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States door Laura E. Stevens (14961009)

Supplementary Table S6 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States door Laura E. Stevens (14961009)

Supplementary Table S7 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States door Laura E. Stevens (14961009)

Supplementary Table S9 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States door Laura E. Stevens (14961009)

Supplementary Table S1 from JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States door Laura E. Stevens (14961009)

Zoekinstrumenten: